mTOR inhibitors in polycystic kidney disease

MeSH terms

• Everolimus
• Humans
• Intracellular Signaling Peptides and Proteins / antagonists & inhibitors*
• Kidney / drug effects*
• Kidney / pathology
• Organ Size / drug effects
• Polycystic Kidney, Autosomal Dominant / drug therapy*
• Polycystic Kidney, Autosomal Dominant / pathology
• Protein Serine-Threonine Kinases / antagonists & inhibitors*
• Sirolimus / analogs & derivatives*
• Sirolimus / therapeutic use*
• TOR Serine-Threonine Kinases